- Home
- JNJ
JNJ
Johnson & Johnson
as 02-21-2025 4:00pm EST
| Founded: | 1886 | Country: | United States |
| Employees: | N/A | City: | NEW BRUNSWICK |
| Market Cap: | N/A | IPO Year: | 1944 |
| Target Price: | $169.76 | AVG Volume (30 days): | 8.8M |
| Analyst Decision: | Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.79 | EPS Growth: | -57.81 |
| 52 Week Low/High: | $140.68 - $168.85 | Next Earning Date: | 04-15-2025 |
| Revenue: | $88,821,000,000 | Revenue Growth: | 4.30% |
| Revenue Growth (this year): | 2.12% | Revenue Growth (next year): | 4.10% |
Stock Insider Trading Activity of Johnson & Johnson (JNJ)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Schmid Timothy | JNJ | EVP, WW Chair, MedTech | Feb 13 '25 | Sell | $156.15 | 403 | $62,928.45 | 15,098 | |
| Wolk Joseph J | JNJ | Exec VP, CFO | Feb 7 '25 | Sell | $153.89 | 13,015 | $2,002,878.35 | 0 | |
| WEINBERGER MARK A | JNJ | Director | Dec 12 '24 | Buy | $147.22 | 1,000 | $147,220.00 | 1,000 |
Latest Johnson & Johnson News
JNJ Breaking Stock News: Dive into JNJ Ticker-Specific Updates for Smart Investing
Simply Wall St.
16 hours ago
Is Johnson & Johnson's (NYSE:JNJ) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Morningstar Research
a day ago
Analyst Report: Johnson & Johnson
Zacks
a day ago
Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue?
Insider Monkey
2 days ago
Is Johnson & Johnson (JNJ) the Best Non-Tech Stock to Buy Now for Long Term?
MT Newswires
2 days ago
Johnson & Johnson's Subcutaneous Ulcerative Colitis Treatment Shows 'Significant' Improvements
PR Newswire
2 days ago
TREMFYA® (guselkumab) subcutaneous (SC) induction data support potential to be the first and only in its class to offer the option of both intravenous and SC induction therapy in ulcerative colitis
Motley Fool
2 days ago
Buy This Ultra-Safe High-Yield Dividend King Stock for Reliable Passive Income
Zacks
3 days ago
Johnson & Johnson (JNJ) Laps the Stock Market: Here's Why
Compare JNJ vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "JNJ Johnson & Johnson - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.